Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Diabetic neuropathy: one disease or two?

Callaghan BC, Hur J, Feldman EL.

Curr Opin Neurol. 2012 Oct;25(5):536-41. doi: 10.1097/WCO.0b013e328357a797. Review.

2.

Enhanced glucose control for preventing and treating diabetic neuropathy.

Callaghan BC, Little AA, Feldman EL, Hughes RA.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD007543. doi: 10.1002/14651858.CD007543.pub2. Review.

3.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
4.

[Diabetic neuropathy: therapeutic nihilism is no longer acceptable].

Haslbeck M.

MMW Fortschr Med. 2007 May 21;149 Suppl 2:24, 26-8, 30. Review. German.

PMID:
17724963
5.

Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short- and long-term outcomes.

Barbour LA.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):257-63. doi: 10.1097/MED.0000000000000079. Review.

PMID:
24937039
6.

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.

Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122. doi: 10.1002/14651858.CD009122.pub2. Review.

PMID:
24526393
7.

Burning through the pain: treatments for diabetic neuropathy.

Javed S, Alam U, Malik RA.

Diabetes Obes Metab. 2015 Dec;17(12):1115-25. doi: 10.1111/dom.12535. Epub 2015 Sep 10. Review.

PMID:
26179288
8.

Mouse models of diabetic neuropathy.

O'Brien PD, Sakowski SA, Feldman EL.

ILAR J. 2014;54(3):259-72. doi: 10.1093/ilar/ilt052. Review.

9.

Painful diabetic neuropathy.

Peltier A, Goutman SA, Callaghan BC.

BMJ. 2014 May 6;348:g1799. doi: 10.1136/bmj.g1799. Review. Erratum in: BMJ. 2014;348:g3440.

PMID:
24803311
10.

The effects of improved glycemic control on complications in type 2 diabetes.

Gaster B, Hirsch IB.

Arch Intern Med. 1998 Jan 26;158(2):134-40. Review.

PMID:
9448551
11.

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.

Schemmel KE, Padiyara RS, D'Souza JJ.

J Diabetes Complications. 2010 Sep-Oct;24(5):354-60. doi: 10.1016/j.jdiacomp.2009.07.005. Epub 2009 Sep 11. Review.

PMID:
19748287
12.
13.

Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan.

Urakami T, Suzuki J, Mugishima H, Amemiya S, Sugihara S, Kawamura T, Kikuchi T, Sasaki N, Matsuura N, Kitagawa T.

Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:51-61. Review.

PMID:
23330246
14.

Diabetes mellitus and its chronic complications.

Bailes BK.

AORN J. 2002 Aug;76(2):266-76, 278-82; quiz 283-6. Review.

PMID:
12194653
15.

A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.

Poh ZX, Goh KP.

Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):392-8. Review.

PMID:
19601918
16.

Medical strategies to reduce amputation in patients with type 2 diabetes.

Malik RA, Tesfaye S, Ziegler D.

Diabet Med. 2013 Aug;30(8):893-900. doi: 10.1111/dme.12169. Review.

PMID:
23445087
17.

Pathological mechanisms involved in diabetic neuropathy: can we slow the process?

Sima AA.

Curr Opin Investig Drugs. 2006 Apr;7(4):324-37. Review.

PMID:
16625819
18.

Diabetic gastroparesis.

Koch KL, Calles-Escandón J.

Gastroenterol Clin North Am. 2015 Mar;44(1):39-57. doi: 10.1016/j.gtc.2014.11.005. Review.

PMID:
25667022
19.

Therapy for diabetic neuropathy: an overview.

Calabek B, Callaghan B, Feldman EL.

Handb Clin Neurol. 2014;126:317-33. doi: 10.1016/B978-0-444-53480-4.00022-9. Review.

PMID:
25410231
20.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124

Supplemental Content

Support Center